Chronic progressive external ophthalmoplegia with ragged-red fibers: Clinical, morphological and genetic investigations in 43 patients

[1]  S. Dimauro,et al.  Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA , 1993, Neuromuscular Disorders.

[2]  N. Romero,et al.  Analysis of the tissue distribution and inheritance of heteroplasmic mitochondrial DNA point mutation by denaturing gradient gel electrophoresis in merrf syndrome , 1992, Neuromuscular Disorders.

[3]  E. Holme,et al.  Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres , 1992, Journal of the Neurological Sciences.

[4]  J. Graham,et al.  Deletion in Blood Mitochondrial DNA in Kearns-Sayre Syndrome , 1992, Pediatric Research.

[5]  I. Nonaka,et al.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  S. Dimauro,et al.  The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. , 1992, American journal of human genetics.

[7]  A. Harding,et al.  A molecular genetic study of focal histochemical defects in mitochondrial encephalomyopathies. , 1992, Brain : a journal of neurology.

[8]  E. Schon,et al.  Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. , 1992, Molecular and cellular biology.

[9]  J. Cooper,et al.  Evidence for intramitochondrial complementation between deleted and normal mitochondrial DNA in some patients with mitochondrial myopathy , 1992, Journal of the Neurological Sciences.

[10]  M. Zeviani,et al.  Neurological disorders due to mutations of the mitochondrial genome , 1991, Neuromuscular Disorders.

[11]  J. Hayashi,et al.  Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Engel,et al.  Mitochondrial DNA deletions in mitochondrial cytopathies , 1991, Neurology.

[13]  S. Dimauro,et al.  mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. , 1991, American journal of human genetics.

[14]  F. Mastaglia,et al.  Functional respiratory chain studies in subjects with chronic progressive external ophthalmoplegia and large heteroplasmic mitochondrial DNA deletions , 1991, Journal of the Neurological Sciences.

[15]  N. Romero,et al.  Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: Genetic, biochemical and morphological studies , 1991, Journal of the Neurological Sciences.

[16]  Ikuya Nonaka,et al.  Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies , 1990, Journal of the Neurological Sciences.

[17]  M. García Román,et al.  [Progressive external ophthalmoplegia]. , 1990, Anales de medicina interna.

[18]  E. Holme,et al.  Progressive Increase of the Mutated Mitochondrial DNA Fraction in Kearns-Sayre Syndrome , 1990, Pediatric Research.

[19]  E. Shoubridge,et al.  Deletion mutants are functionally dominant over wild-type mitochondrial genomes in skeletal muscle fiber segments in mitochondrial disease , 1990, Cell.

[20]  S. Dimauro,et al.  Transcription and translation of deleted mitochondrial genomes in Kearns-Sayre syndrome: implications for pathogenesis. , 1990, American journal of human genetics.

[21]  J. Cooper,et al.  Mitochondrial myopathies: Clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA , 1989, Annals of neurology.

[22]  S. Dimauro,et al.  An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region , 1989, Nature.

[23]  S. Dimauro,et al.  Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. , 1989, The New England journal of medicine.

[24]  S. Dimauro,et al.  Deletions of mitochondrial DNA in Kearns‐Sayre syndrome , 1988, Neurology.

[25]  G. Ponsot,et al.  KEARNS-SAYRE SYNDROME WITH MUSCLE MITOCHONDRIAL DNA DELETION , 1988, The Lancet.

[26]  A. Harding,et al.  Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies , 1988, Nature.

[27]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[28]  N. Bresolin,et al.  Progressive cytochrome c oxidase deficiency in a case of earns‐sayre syndrome: Morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues , 1987, Annals of neurology.

[29]  A. Harding,et al.  The clinical features of mitochondrial myopathy. , 1986, Brain : a journal of neurology.

[30]  J. Erickson,et al.  Variation among human 28S ribosomal RNA genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Nemni,et al.  Chronic progressive external ophthalmoplegia (CPEO) , 1983, Neurology.

[32]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[33]  J. Drouin.  Cloning of human mitochondrial DNA in Escherichia coli. , 1980, Journal of molecular biology.

[34]  E. Joosten,et al.  Ophthalmoplegia‐plus, a real nosological entity , 1978, Acta neurologica Scandinavica.

[35]  S. Dimauro,et al.  Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome? , 1977, Annals of neurology.

[36]  W. Engel,et al.  Oculocraniosomatic Neuromuscular Disease With Ragged-Red Fibers: Histochemical and Ultrastructural Changes in Limb Muscles of a Group of Patients With Idiopathic Progressive External Ophthalmoplegia , 1972 .

[37]  Jacob S. Hanker,et al.  NONDROPLET ULTRASTRUCTURAL DEMONSTRATION OF CYTOCHROME OXIDASE ACTIVITY WITH A POLYMERIZING OSMIOPHILIC REAGENT, DIAMINOBENZIDINE (DAB) , 1968, The Journal of cell biology.

[38]  D. Drachman.  Ophthalmoplegia Plus: The Neurodegenerative Disorders Associated With Progressive External Ophthalmoplegia , 1968 .

[39]  G. P. Sayre,et al.  Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. , 1958, A.M.A. archives of ophthalmology.

[40]  S. Dimauro,et al.  Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. , 1994, Human molecular genetics.

[41]  D. Wallace,et al.  Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.

[42]  H. Reichmann,et al.  Histological, enzymatic and mitochondrial DNA studies in patients with Kearns-Sayre syndrome and chronic progressive external ophthalmoplegia. , 1991, European neurology.

[43]  R. Myers,et al.  Detection and localization of single base changes by denaturing gradient gel electrophoresis. , 1987, Methods in enzymology.

[44]  D. Drachman.  Ophthalmoplegia plus: A classification of the disorders associated with progressive external ophthalmoplegia , 1975 .

[45]  V. Dubowitz,et al.  Muscle biopsy: A modern approach , 1973 .